Anti-viral innate immunity: Is it where type 1 diabetes really begins?

Diabetes Metab Res Rev. 2023 Jul;39(5):e3623. doi: 10.1002/dmrr.3623. Epub 2023 Feb 17.

Authors

Sara Bruzzaniti¹, Erica Piemonte², Maria Teresa Lepore¹, Mario Galgani^{1

2}

Affiliations

¹ Institute Experimental Endocrinology and Oncology "G. Salvatore", National Research Council, Naples, Italy.
² Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.

PMID: 36764821
DOI: 10.1002/dmrr.3623

No abstract available

MeSH terms

Antiviral Agents
Diabetes Mellitus, Type 1*
Humans
Immunity, Innate

Substances

Antiviral Agents

Grants and funding